Mefloquine concentration profiles during prophylactic dose regimens

Wiener Klinische Wochenschrift

Volumn 112, Issue 10, 2000, Pages 441-447

  Kollaritsch, Herwig ^b   Karbwang, Juntra ^a   Wiedermann, Gerhard ^c   Mikolasek, Andrea ^c   Na Bangchang, Kesara ^a   Wernsdorfer, Walter H ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF VIENNA   (Austria)

^c NONE

Author keywords

Adverse reactions; Gender; Malaria prophylaxis; Mefloquine; Pharmacokinetics

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; MEFLOQUINE;

ADULT; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DRUG BLOOD LEVEL; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; MALARIA; MALE; NORMAL HUMAN; PROPHYLAXIS; SEX DIFFERENCE; VERTIGO;

ADULT; ANTIMALARIALS; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALARIA; MALE; MEFLOQUINE; REFERENCE VALUES; SEX FACTORS;

EID: 0034685908     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. World Health Organization (1999) International travel and health. WHO, Geneva
2. World Health Organization (1984) Advances in malaria chemotherapy. Report of a WHO Scientific Group. WHO Tech Rep Ser no 711. WHO, Geneva
3. Behrens RH, Bradley RW, Snow RW, Marsh K (1996) Impact of UK malaria prophylaxis on imported malaria. Lancet 348: 344-345
4. Clift S, Grabowski P (1996) Malaria prophylaxis and the media. Lancet 348: 344.
5. Croft AMJ, Garner P (1997) Mefloquine to prevent malaria: a systemic review of clinical trials. Br Med J 315: 1412-1416
6. World Health Organization (1990) Practical chemotherapy of malaria. Report of a WHO Scientific Group. WHO Tech Rep Ser no 805. WHO, Geneva
7. Desjardins RE, Pamplin CL, von Bredow J, Barry KG, Canfield CJ (1979) Kinetics of a new antimalarial, mefloquine. Clin Pharm Ther 26: 372-379
8. Bruce-Chwatt LJ, Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer WH (1982) Chemotherapy of malaria, 2nd rev edn. WHO, Geneva
9. Karbwang J, Molunto P, Na-Bangchang K, Bunnag D (1989) Determination of mefloquine in biological fluids using high performance liquid chromatography. Southeasr Asian J Trop Med Publ Hlth 20: 55-60
10. Benet LZ, Mitchell JR, Scheiner LB (1991) Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 3-32
11. Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L (1993) Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 44: 257-265
12. Gimenez F, Pennie RA, Koren G, Crevoisier C, Wainer IW, Farinotti R (1994) Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. J Pharm Sci 83: 824-827
13. Karbwang J, White NJ (1990) Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 19: 164-279.
14. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC (1993) Long-term malaria prophylaxis with mefloquine. Lancet 341: 848-851
15. Pennie RA, Koren G, Crevoisier C (1993) Steady state pharmacokinetics of mefloquine in long-term travellers. Trans R Soc Trop Med Hyg 87: 459-462
16. Mimica I, Fry W, Eckert G, Schwartz DE (1983) Multiple dose kinetic study of mefloquine in healthy male volunteers. Chemotherapy 29: 184-187
17. Crevoisier C, Handschin J, Barre J, Roumenov D, Kleinbloesem C (1997) Food increases the bioavailability of mefloquine. Eur J Clin Pharmacol 53: 135-139
18. Nosten F, Karbwang J, White NJ, Honeymoon, Na Bangchang K, Bunnag D, Harinasuta T (1990) Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. Br J Clin Pharmacol 30: 79-85
19. Karbwang J, Na-Bangchang K (1994) Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria. Fundam Clin Pharmacol 8: 491-502
20. Looareesuwan S, White NJ, Warrell DA, Forgo I, Dubach UG, Ranalder UB, Schwartz DE (1987) Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol 24: 37-42
21. Schlagenhauf P, Steffen R, Lobel H, Johnson R. Letz R, Tschopp A, Vranjes N, Bergqvist Y, Ericsson O, Hellgren U, Rombo L, Mannino S, Handschin J, Stürchler D (1996) Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Hlth 1: 485-494
22. Na-Bangchang K, Molunto P, Banmairuroi V, Thanavibul A, Karbwang J (1995) Pharmacokinetics of mefloquine when given as a single and two divided-dose regimens. Int J Clin Pharm Res 15: 215-220
23. Lell B, Luckner D, Ndjavé M, Scott T, Kremsner PG (1998) Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 351: 709-713